Christopher Barnes : part I - SARS COV2 broadly neutralizing antibodies

https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/c3/b3/b2/c3b3b290-bd29-7078-548d-58c02a125b9f/mza_6886560138527518259.jpg/600x600bb.jpg

cryo2go

Benjamin Himes

7 episodes

2 months ago

cryoEM related publications discussed with the authors, to get the story behind the science.

If you have comments, questions, complaints or requests for a specific paper, please hmu on Twitter @cryo2go with a link to the episode.

Science

RSS

All content for cryo2go is the property of Benjamin Himes and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Science

https://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/a7babebb3ed3e07487c2fadec9688461.jpg

Christopher Barnes : part I - SARS COV2 broadly neutralizing antibodies

cryo2go

48 minutes

4 years ago

Christopher Barnes : part I - SARS COV2 broadly neutralizing antibodies

In this episode, we get to hear from Dr. Christopher Barnes, currently at Caltech, about his research combining structural biology and immunology. Christopher was able to rapidly deploy his expertise developed in studying the HIV virus to the emerging SARS-COV-2 outbreak early in the pandemic, publishing this article in May 2020.

See here in Cell (https://www.cell.com/cell/fulltext/S0092-8674(20)30757-1?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0092867420307571%3Fshowall%3Dtrue)

This interview was recorded in June 2020 amid escalating calls for police reform and social justice in a country that has a long history of racial inequity. In the next episode, part II, we talk about how and when scientists should get involved in issues that many of us, myself included, shy away from.

Between publishing 13 papers in 2020 and locking down an Assistant Professorship at Stanford starting summer 2021, I count myself luck that Christopher made time to sit down and talk with me.

Enjoy the show!